{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T13:39:20Z","timestamp":1791207560023,"version":"4.1.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":1218,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100011960","name":"Debra International","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011960","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1038\/jid.2012.101","type":"journal-article","created":{"date-parts":[[2012,4,12]],"date-time":"2012-04-12T08:26:19Z","timestamp":1334219179000},"page":"1959-1966","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":78,"title":["Spliceosome-Mediated Trans-Splicing: The Therapeutic Cut and Paste"],"prefix":"10.1016","volume":"132","author":[{"given":"Verena","family":"Wally","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva M.","family":"Murauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johann W.","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/jid.2012.101_bb0010","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1182\/asheducation-2009.1.682","article-title":"Ten years of gene therapy for primary immune deficiencies","volume":"2009","author":"Aiuti","year":"2009","journal-title":"Hematology Am Soc Hematol Educ Prog"},{"key":"10.1038\/jid.2012.101_bb0015","doi-asserted-by":"crossref","first-page":"8693","DOI":"10.1073\/pnas.0402772101","article-title":"Molecular imaging of gene expression in living subjects by spliceosome-mediated RNA trans-splicing","volume":"101","author":"Bhaumik","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/jid.2012.101_bb0020","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1038\/3233","article-title":"Thymic lymphoproliferative disease after successful correction of CD40 ligand deficiency by gene transfer in mice","volume":"4","author":"Brown","year":"1998","journal-title":"Nat Med"},{"key":"10.1038\/jid.2012.101_bb0025","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1261\/rna.5450203","article-title":"Efficient and specific repair of sickle beta-globin RNA by trans-splicing ribozymes","volume":"9","author":"Byun","year":"2003","journal-title":"RNA"},{"key":"10.1038\/jid.2012.101_bb0030","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1083\/jcb.152.3.651","article-title":"An inducible mouse model for epidermolysis bullosa simplex: implications for gene therapy","volume":"152","author":"Cao","year":"2001","journal-title":"J Cell Biol"},{"key":"10.1038\/jid.2012.101_bb0035","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1038\/nm900","article-title":"Phenotype correction of hemophilia A mice by spliceosome-mediated RNA trans-splicing","volume":"9","author":"Chao","year":"2003","journal-title":"Nat Med"},{"key":"10.1038\/jid.2012.101_bb0040","doi-asserted-by":"crossref","first-page":"e3468","DOI":"10.1371\/journal.pone.0003468","article-title":"Development of a single vector system that enhances trans-splicing of SMN2 transcripts","volume":"3","author":"Coady","year":"2008","journal-title":"Plos One"},{"key":"10.1038\/jid.2012.101_bb0045","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1523\/JNEUROSCI.4489-09.2010","article-title":"Trans-splicing-mediated improvement in a severe mouse model of spinal muscular atrophy","volume":"30","author":"Coady","year":"2010","journal-title":"J Neurosci"},{"key":"10.1038\/jid.2012.101_bb0050","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1038\/sj.mt.6300222","article-title":"Restoration of SMN function: delivery of a trans-splicing RNA re-directs SMN2 pre-mRNA splicing","volume":"15","author":"Coady","year":"2007","journal-title":"Mol Ther"},{"key":"10.1038\/jid.2012.101_bb0055","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1034\/j.1600-0625.2003.120105.x","article-title":"Development of spliceosome-mediated RNA trans-splicing (SMaRT) for the correction of inherited skin diseases","volume":"12","author":"Dallinger","year":"2003","journal-title":"Exp Dermatol"},{"key":"10.1038\/jid.2012.101_bb0060","doi-asserted-by":"crossref","first-page":"21813","DOI":"10.1074\/jbc.270.37.21813","article-title":"RNA trans-splicing in flatworms. Analysis of trans-spliced mRNAs and genes in the human parasite, Schistosoma mansoni","volume":"270","author":"Davis","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1038\/jid.2012.101_bb0065","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.nbt.2010.02.013","article-title":"RNA reprogramming and repair based on trans-splicing group I ribozymes","volume":"27","author":"Fiskaa","year":"2010","journal-title":"New Biotechnol"},{"key":"10.1038\/jid.2012.101_bb0070","doi-asserted-by":"crossref","first-page":"26244","DOI":"10.1074\/jbc.M203513200","article-title":"Natural trans-spliced mRNAs are generated from the human estrogen receptor-alpha (hER alpha) gene","volume":"277","author":"Flouriot","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1038\/jid.2012.101_bb0075","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1126\/science.175.4025.949","article-title":"Gene therapy for human genetic disease?","volume":"175","author":"Friedmann","year":"1972","journal-title":"Science"},{"key":"10.1038\/jid.2012.101_bb0080","doi-asserted-by":"crossref","first-page":"30248","DOI":"10.1074\/jbc.M109.045294","article-title":"Dominant negative effects of COL7A1 mutations can be rescued by controlled over-expression of normal collagen VII","volume":"284","author":"Fritsch","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1038\/jid.2012.101_bb0085","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1158\/1535-7163.MCT-10-0669","article-title":"Spliceosome-mediated RNA trans-splicing facilitates targeted delivery of suicide genes to cancer cells","volume":"10","author":"Gruber","year":"2011","journal-title":"Mol Cancer Ther"},{"key":"10.1038\/jid.2012.101_bb0090","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jns.2009.08.055","article-title":"Is RNA manipulation a viable therapy for spinal muscular atrophy?","volume":"287","author":"Horne","year":"2009","journal-title":"J Neurol Sci"},{"key":"10.1038\/jid.2012.101_bb0095","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.bbrc.2009.04.122","article-title":"Trans-splicing as a novel method to rapidly produce antibody fusion proteins","volume":"384","author":"Iwasaki","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1038\/jid.2012.101_bb0100","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.bbrc.2004.07.203","article-title":"Restoration of protein synthesis in pancreatic cancer cells by trans-splicing ribozymes","volume":"322","author":"Kastanos","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1038\/jid.2012.101_bb0105","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1261\/rna.525607","article-title":"Using 5\u2032-PTMs to repair mutant beta-globin transcripts","volume":"13","author":"Kierlin-Duncan","year":"2007","journal-title":"RNA"},{"key":"10.1038\/jid.2012.101_bb0110","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1089\/104303401750298580","article-title":"Promiscuity of pre-mRNA spliceosome-mediated trans splicing: a problem for gene therapy?","volume":"12","author":"Kikumori","year":"2001","journal-title":"Hum Gene Ther"},{"key":"10.1038\/jid.2012.101_bb0115","first-page":"S1451","article-title":"Improvement of RNA trans-splicing based gene correction using a RTM screening system","volume":"21","author":"Koller","year":"2010","journal-title":"Hum Gene Ther"},{"key":"10.1038\/jid.2012.101_bb0120","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1093\/nar\/gkr465","article-title":"A novel screening system improves genetic correction by internal exon replacement","volume":"39","author":"Koller","year":"2011","journal-title":"Nuc Acids Res"},{"key":"10.1038\/jid.2012.101_bb0125","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1089\/hum.2005.16.1116","article-title":"Spliceosome-mediated RNA trans-splicing with recombinant adeno-associated virus partially restores cystic fibrosis transmembrane conductance regulator function to polarized human cystic fibrosis airway epithelial cells","volume":"16","author":"Liu","year":"2005","journal-title":"Hum Gene Ther"},{"key":"10.1038\/jid.2012.101_bb0130","doi-asserted-by":"crossref","first-page":"e10894","DOI":"10.1371\/journal.pone.0010894","article-title":"Exon exchange approach to repair duchenne dystrophin transcripts","volume":"5","author":"Lorain","year":"2010","journal-title":"Plos One"},{"key":"10.1038\/jid.2012.101_bb0135","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1261\/rna.5101903","article-title":"5\u2032 exon replacement and repair by spliceosome-mediated RNA trans-splicing","volume":"9","author":"Mansfield","year":"2003","journal-title":"RNA"},{"key":"10.1038\/jid.2012.101_bb0140","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1038\/nm1504","article-title":"Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells","volume":"12","author":"Mavilio","year":"2006","journal-title":"Nat Med"},{"key":"10.1038\/jid.2012.101_bb0145","first-page":"S68","article-title":"A 5\u2032 trans-splicing gene therapy approach for dystrophic epidermolysis bullosa","volume":"131","author":"Mayr","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2012.101_bb0150","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1038\/sj.gt.3302596","article-title":"Gene therapy progress and prospects: reprograming gene expression by trans-splicing","volume":"12","author":"Mitchell","year":"2005","journal-title":"Gene Ther"},{"key":"10.1038\/jid.2012.101_bb0155","volume":"228","author":"Morris","year":"2008"},{"key":"10.1038\/jid.2012.101_bb0160","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/jid.2010.249","article-title":"Functional correction of type VII collagen expression in dystrophic epidermolysis bullosa","volume":"131","author":"Murauer","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2012.101_bb0165","first-page":"S75","article-title":"3\u2032 trans-splicing repair of COL7A1 mutations in recessive dystrophic epidermolysis bullosa patients","volume":"130","author":"Murauer","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2012.101_bb0170","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/0092-8674(86)90616-1","article-title":"Identification of a novel Y branch structure as an intermediate in trypanosome mRNA processing: evidence for trans splicing","volume":"47","author":"Murphy","year":"1986","journal-title":"Cell"},{"key":"10.1038\/jid.2012.101_bb0175","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1158\/0008-5472.254.65.1","article-title":"Gene transfer-mediated pre-mRNA segmental trans-splicing as a strategy to deliver intracellular toxins for cancer therapy","volume":"65","author":"Nakayama","year":"2005","journal-title":"Cancer Res"},{"key":"10.1038\/jid.2012.101_bb0180","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1100\/tsw.2010.67","article-title":"Genetic correction of sickle cell anemia and beta-thalassemia: progress and new perspective","volume":"10","author":"Perumbeti","year":"2010","journal-title":"Scientific World Journal"},{"key":"10.1038\/jid.2012.101_bb0185","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1006\/mthe.2001.0426","article-title":"Messenger RNA repair and restoration of protein function by spliceosome-mediated RNA trans-splicing","volume":"4","author":"Puttaraju","year":"2001","journal-title":"Mol Ther"},{"key":"10.1038\/jid.2012.101_bb0190","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/6986","article-title":"Spliceosome-mediated RNA trans-splicing as a tool for gene therapy","volume":"17","author":"Puttaraju","year":"1999","journal-title":"Nat Biotechnol"},{"key":"10.1038\/jid.2012.101_bb0195","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1093\/hmg\/ddp264","article-title":"Correction of tau mis-splicing caused by FTDP-17 MAPT mutations by spliceosome-mediated RNA trans-splicing","volume":"18","author":"Rodriguez-Martin","year":"2009","journal-title":"Hum Mol Genet"},{"key":"10.1038\/jid.2012.101_bb0200","doi-asserted-by":"crossref","first-page":"15659","DOI":"10.1073\/pnas.0503150102","article-title":"Reprogramming of tau alternative splicing by spliceosome-mediated RNA trans-splicing: implications for tauopathies","volume":"102","author":"Rodriguez-Martin","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/jid.2012.101_bb0205","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jim.2003.08.006","article-title":"In-cell generation of antibody single-chain Fv transcripts by targeted RNA trans-splicing","volume":"282","author":"Schlesinger","year":"2003","journal-title":"J Immunol Meth"},{"key":"10.1038\/jid.2012.101_bb0210","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1089\/hum.2010.114","article-title":"Combination of SMN trans-splicing and a neurotrophic factor increases the life span and body mass in a severe model of spinal muscular atrophy","volume":"22","author":"Shababi","year":"2011","journal-title":"Hum Gene Ther"},{"key":"10.1038\/jid.2012.101_bb0215","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s12031-011-9614-3","article-title":"Optimization of SMN trans-splicing through the analysis of SMN introns","volume":"46","author":"Shababi","year":"2011","journal-title":"J Mol Neurosci"},{"key":"10.1038\/jid.2012.101_bb0220","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.ymthe.2004.05.007","article-title":"Ribozyme-mediated induction of apoptosis in human cancer cells by targeted repair of mutant p53 RNA","volume":"10","author":"Shin","year":"2004","journal-title":"Mol Ther"},{"key":"10.1038\/jid.2012.101_bb0225","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/nature07754","article-title":"On the road to reading the RNA-interference code","volume":"457","author":"Siomi","year":"2009","journal-title":"Nature"},{"key":"10.1038\/jid.2012.101_bb0230","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1089\/hum.2008.173","article-title":"Functional cystic fibrosis transmembrane conductance regulator expression in cystic fibrosis airway epithelial cells by AAV6.2-mediated segmental trans-splicing","volume":"20","author":"Song","year":"2009","journal-title":"Hum Gene Ther"},{"key":"10.1038\/jid.2012.101_bb0235","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/371619a0","article-title":"Ribozyme-mediated repair of defective mRNA by targeted, trans-splicing","volume":"371","author":"Sullenger","year":"1994","journal-title":"Nature"},{"key":"10.1038\/jid.2012.101_bb0240","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/nm1086","article-title":"Trans-splicing repair of CD40 ligand deficiency results in naturally regulated correction of a mouse model of hyper-IgM X-linked immunodeficiency","volume":"10","author":"Tahara","year":"2004","journal-title":"Nat Med"},{"key":"10.1038\/jid.2012.101_bb0245","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.2967\/jnumed.107.047662","article-title":"A generalizable strategy for imaging pre-mRNA levels in living subjects using spliceosome-mediated RNA trans-splicing","volume":"49","author":"Walls","year":"2008","journal-title":"J Nucl Med"},{"key":"10.1038\/jid.2012.101_bb0250","doi-asserted-by":"crossref","first-page":"4715","DOI":"10.1093\/hmg\/ddq405","article-title":"K14 mRNA reprogramming for dominant epidermolysis bullosa simplex","volume":"19","author":"Wally","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.1038\/jid.2012.101_bb0255","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/sj.jid.5701152","article-title":"5\u2032 trans-splicing repair of the PLEC1 gene","volume":"128","author":"Wally","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2012.101_bb0260","series-title":"Genetic Disease","article-title":"High-throughput screening for highly functional RNA-trans-splicing molecules: correction of plectin in epidermolysis bullosa simplex","author":"Wally","year":"2011"},{"key":"10.1038\/jid.2012.101_bb0265","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/mt.2008.260","article-title":"Trans-splicing into highly abundant albumin transcripts for production of therapeutic proteins in vivo","volume":"17","author":"Wang","year":"2009","journal-title":"Mol Ther"},{"key":"10.1038\/jid.2012.101_bb0270","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1091\/mbc.e03-09-0687","article-title":"Epidermolysis bullosa simplex-type mutations alter the dynamics of the keratin cytoskeleton and reveal a contribution of actin to the transport of keratin subunits","volume":"15","author":"Werner","year":"2004","journal-title":"Mol Biol Cell"},{"key":"10.1038\/jid.2012.101_bb0275","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.ymthe.2005.09.006","article-title":"Spliceosome-mediated RNA trans-splicing","volume":"12","author":"Yang","year":"2005","journal-title":"Mol Ther"},{"key":"10.1038\/jid.2012.101_bb0280","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1038\/sj.mt.6300178","article-title":"Correction of DNA protein kinase deficiency by spliceosome-mediated RNA trans-splicing and sleeping beauty transposon delivery","volume":"15","author":"Zayed","year":"2007","journal-title":"Mol Ther"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15358565?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15358565?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T18:12:39Z","timestamp":1743963159000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X15358565"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":55,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S0022202X15358565"],"URL":"https:\/\/doi.org\/10.1038\/jid.2012.101","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Spliceosome-Mediated Trans-Splicing: The Therapeutic Cut and Paste","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/jid.2012.101","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 The Society for Investigative Dermatology, Inc. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}